健康行为干预的长期成本效益,以管理尼泊尔的2型糖尿病
Padam Kanta Dahal1,2, Corneel Vandelanotte3, Lal Rawal4,3,5
1School of Health, Medical and Applied Sciences, Central Queensland University, Sydney Campus, 400 Kent Street, NSW, Rockhampton, 2000, Australia. padamdahal1@gmail.com.
BMC medicine
|March 12, 2025
概括
在尼泊尔,健康行为干预有效地管理了2型糖尿病 (T2DM),证明了终身的成本效益. 这种干预改善了质量调整寿命年 (QALYs),并为低收入国家提供了显著的长期经济效益.
科学领域:
- 卫生经济学 卫生经济学
- 公共卫生干预措施 公共卫生干预
- 糖尿病管理 糖尿病管理
背景情况:
- 成本效益分析对于低收入国家的2型糖尿病 (T2DM) 管理至关重要.
- 优化资源配置和最大限度地减少经济负担是关键目标.
研究的目的:
- 估计尼泊尔T2DM管理的健康行为干预措施的长期成本效益.
- 从医疗保健系统和社会角度来看,比较干预与常规护理.
主要方法:
- 使用了结合决策树的马尔科夫模型.
- 经验试验数据和已发表的数据为模型参数提供了信息.
- 成本,质量调整寿命年 (QALYs) 和成本效益估计在不同的时间范围内 (5-30年和寿命),每年折扣为3%.
主要成果:
- 干预改善了QALY的3.88和成本的增加,产生一个增量成本效益比 (ICER) 的$ 1106 / QALY (医疗保健系统) 和$ 1173 / QALY (社会) 在一个终身的地平线.
- 短期ICER在不同视角和时间范围内从632美元到766美元/QALY不等.
- 概率敏感性分析表明,成本效益的概率超过57%.
结论:
- 对T2DM的健康行为干预在终身时间范围内具有成本效益.
- 建议在全国范围内扩大规模,以最大限度地发挥影响.
- 需要在各种低收入环境中对长期成本效益进行进一步的研究.
相关概念视频
Diabetes: Management and Pharmacotherapy
222
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
222
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
495
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Insulin: Dosing Regimen and Adverse Effects
136
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
136


